Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS)
CUSIP: 00461U105
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Shares outstanding
- 121,058,810
- Total 13F shares
- 58,449,543
- Share change
- -12,189,429
- Total reported value
- $61,369,526
- Put/Call ratio
- 112%
- Price per share
- $1.05
- Number of holders
- 102
- Value change
- -$207,123,774
- Number of buys
- 59
- Number of sells
- 82
Quarterly Holders Quick Answers
What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00461U105:
Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
5.8%
|
7,064,736
|
$48,393,442 | — | 30 Sep 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.8%
|
6,979,844
|
$47,811,932 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.6%
|
5,607,890
|
$38,414,046 | — | 30 Sep 2023 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.6%
|
4,398,453
|
$30,129,403 | — | 30 Sep 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
3.3%
|
3,960,449
|
$27,129,076 | — | 30 Sep 2023 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
2.8%
|
3,400,000
|
$23,290,000 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
3,363,046
|
$23,036,866 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.8%
|
3,357,240
|
$22,997,094 | — | 30 Sep 2023 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
2.3%
|
2,808,034
|
$19,235,033 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.6%
|
1,967,980
|
$13,480,663 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
1,698,391
|
$11,633,979 | — | 30 Sep 2023 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.4%
|
1,691,768
|
$11,588,611 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
1,562,508
|
$10,703,180 | — | 30 Sep 2023 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
1.2%
|
1,463,074
|
$10,022,057 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,337,082
|
$9,160,010 | — | 30 Sep 2023 | |
| Blackstone Inc. |
13F
|
Company |
1%
|
1,261,425
|
$8,640,761 | — | 30 Sep 2023 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
1%
|
1,258,243
|
$8,618,965 | — | 30 Sep 2023 | |
| VR Adviser, LLC |
13F
|
Company |
0.86%
|
1,040,754
|
$7,129,165 | — | 30 Sep 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.83%
|
1,000,000
|
$6,850,000 | — | 30 Sep 2023 | |
| Vivo Capital, LLC |
13F
|
Company |
0.74%
|
898,631
|
$6,155,622 | — | 30 Sep 2023 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.58%
|
696,171
|
$4,768,771 | — | 30 Sep 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.57%
|
687,135
|
$4,706,875 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.55%
|
662,529
|
$4,538,324 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0.55%
|
661,300
|
$4,529,905 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
659,371
|
$4,516,692 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.53%
|
647,652
|
$4,436,000 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.38%
|
463,234
|
$3,173,153 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.38%
|
460,313
|
$3,153,144 | — | 30 Sep 2023 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.37%
|
453,954
|
$3,110,000 | — | 30 Sep 2023 | |
| Aisling Capital Management LP |
13F
|
Company |
0.36%
|
434,455
|
$2,976,017 | — | 30 Sep 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.33%
|
403,000
|
$2,760,550 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.33%
|
400,321
|
$2,742,200 | — | 30 Sep 2023 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.31%
|
369,802
|
$2,534,000 | — | 30 Sep 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.25%
|
299,685
|
$2,052,842 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
272,821
|
$1,868,824 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.22%
|
269,746
|
$1,847,759 | — | 30 Sep 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.22%
|
264,377
|
$1,810,982 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.22%
|
261,733
|
$1,792,871 | — | 30 Sep 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.2%
|
246,587
|
$1,669,394 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
242,770
|
$1,662,975 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
234,150
|
$1,603,929 | — | 30 Sep 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.17%
|
201,233
|
$1,378,446 | — | 30 Sep 2023 | |
| Caption Management, LLC |
13F
|
Company |
0.16%
|
190,000
|
$1,301,500 | — | 30 Sep 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.14%
|
175,481
|
$1,202,045 | — | 30 Sep 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.14%
|
170,230
|
$1,166,076 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.14%
|
164,060
|
$1,123,811 | — | 30 Sep 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.13%
|
154,309
|
$1,057,016 | — | 30 Sep 2023 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.13%
|
151,704
|
$1,039,000 | — | 30 Sep 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.12%
|
146,454
|
$1,003,000 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
146,000
|
$1,000,100 | — | 30 Sep 2023 |
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) as of Q4 2023
As of 31 Dec 2023,
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,449,543 shares.
The largest 10 holders included
BlackRock Inc., CITADEL ADVISORS LLC, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, MILLENNIUM MANAGEMENT LLC, Rock Springs Capital Management LP, ACADIAN ASSET MANAGEMENT LLC, D. E. Shaw & Co., Inc., Velan Capital Investment Management LP, and TANG CAPITAL MANAGEMENT LLC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
137
Q4 2023 holders
102
Holder diff
-35
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.